"Danaher and Cepheid are using a printer-ink business model to overcharge for tuberculosis tests, thus resulting in millions of people going undiagnosed every year, many of whom will die." Watch the full video here.
top of page
Recent Posts
See AllThe results of the TB-CHAMP trial were recently published. They showed that prophylactic levofloxacin can significantly reduce the risk...
150
This month, the Indian Patent Office denied the last of the three Janssen patent extension applications for bedaquiline. While TB...
80
The Institute of Tropical Medicine has announced two initiatives to honor the legacy of Armand Van Deun: a new meeting room in his name...
540
bottom of page
Comments